CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Renata Solimini

Senior Investigator at the National Centre on Addiction and Doping of the Istituto Superiore di Sanità (Italian National Institute of Health)

OPENALEX: A5091764313↗ORCID: 0000-0001-8737-4504↗

Affiliations

Organizations

Istituto Superiore di Sanitàauthorship · IT

Public evidence

2 connected articles

Cannabidiol Adverse Effects and Toxicity.2019 · Europe PMC A Study on the Reliability of an On-Site Oral Fluid Drug Test in a Recreational Context.2016 · PubMed Central Open Access

Registered research

Connected studies

A Randomized, Open-Label, 4-Way Crossover, Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditionsnct06578455 CBD Cannabis Extract: Pharmacokinetic Studiesnct04280289

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Renata Solimini - Medical Cannabis Research Engine